China approves Blackstone, TPG acquisition of medtech firm Hologic

China's market regulator has approved the acquisition of medical diagnostics firm Hologic by private equity firms Blackstone and TPG. This deal, valued at $18.3 billion, is the largest in medical devices in nearly two decades. Hologic has manufacturing and partnership operations in China. The regulator's approval signifies a significant step in this major transaction.